Nivolumab Is Effective in Mismatch Repair–Deficient Noncolorectal Cancers: Results From Arm Z1D—A Subprotocol of the NCI-MATCH (EAY131) Study

PURPOSE: The National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest national precision oncology study to date (> 1,100 sites) of patients with relapsed or refractory malignancies, assigned patients to targeted therapy in parallel phase II studies based on t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Azad, Nilofer S., Gray, Robert J., Overman, Michael J., Schoenfeld, Jonathan D., Mitchell, Edith P., Zwiebel, James A., Sharon, Elad, Streicher, Howard, Li, Shuli, McShane, Lisa M., Rubinstein, Larry, Patton, David R., Williams, P. Mickey, Coffey, Brent, Hamilton, Stanley R., Bahary, Nathan, Suga, J. Marie, Hatoum, Hassan, Abrams, Jeffrey S., Conley, Barbara A., Arteaga, Carlos L., Harris, Lyndsay, O'Dwyer, Peter J., Chen, Alice P., Flaherty, Keith T.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6968795/
https://ncbi.nlm.nih.gov/pubmed/31765263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.00818
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados